HIV 1 News and Research

RSS

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adult

A new analysis of existing research offers confirmation that taking a break from AIDS drugs is a bad idea for HIV patients with uncontrolled cases of the disease.

19 Jul 2006

Highly active antiretroviral therapies associated with reduced infections in HIV-infected children

Since the introduction of highly active antiretroviral therapies, there has been a substantial reduction of opportunistic infections and other infections in HIV-infected children, such as pneumonia and tuberculosis.

19 Jul 2006

New research shows how 'genetic fingerprinting' can be used to track the spread of STDs

New research shows it could be possible to follow the spread of bacterial sexually transmitted diseases (STDs) through the population by tracking the individuals in a city infected with the same strain of the bacterium.

19 Jul 2006

Clinton Foundation seals deal in Nigerian AIDS fight

The Clinton Foundation, an AIDS charity set up by former U.S. President Bill Clinton, has signed a deal with Nigeria to make cheap AIDS drugs available to fight the disease in Africa's most populous nation.

18 Jul 2006

FDA approves Atripla for the treatment of HIV-1 infection in adults

Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.

13 Jul 2006

FDA approves Atripla three-drug combination tablet for treatment of HIV-1

FDA approves Atripla Tablets, a fixed-dose combination of three widely-used antiretroviral drugs.

12 Jul 2006

Male circumcision the key to controlling the spread of AIDS in Africa

In what is being coined as a 'landmark' trial, researchers have found evidence that male circumcision (MC) could reduce the chance of becoming infected with HIV.

10 Jul 2006

Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot-peptide conjugates

Using a synthetic peptide modeled after the protein that the human immunodeficiency virus (HIV) uses to enter cells, a multi-institutional research team has created quantum dots that can penetrate the cell membrane and image internal structures in a cell.

10 Jul 2006

Psychological torture used on Bulgarian nurses in Libya

At a hearing in Tripoli the defence team representing a Palestinian doctor and five Bulgarian nurses accused of deliberately infecting more than 400 Libyan children with HIV-tainted blood, have said psychological-torture measures were used against the nurses.

6 Jul 2006

Retrial resumes in Tripoli of foreign medics accused of infecting children with HIV

The retrial of five Bulgarian nurses and a Palestinian doctor accused of knowingly infecting hundreds of Libyan children with HIV has resumed in the Libyan capital, Tripoli.

4 Jul 2006

How much do you need to know about your spouse's previous sex life?

Under a new ruling by the California Supreme Court, a person who has reason to believe he or she has HIV may be sued by sexual partners should they become infected.

4 Jul 2006

Researchers develop T-cells from human embryonic stem cells

Human embryonic stem cells can be genetically manipulated and coaxed to develop into mature T-cells, raising hopes for a gene therapy to combat AIDS.

3 Jul 2006

Online information service about HIV/AIDS and hepatitis B

A leading Spanish newspaper has introduced, on its website, an information service about HIV/AIDS and about hepatitis B.

3 Jul 2006

3-drug pill will help fight HIV/AIDS

The Food and Drug Administration (FDA) in the U.S. has granted approval for a three-ingredient fixed dose tablet for use as an antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.

3 Jul 2006

FDA gives tentative approval for generic pediatric AIDS drug

The Food and Drug Administration (FDA) today announced the tentative approval of the generic version of Abacavir Sulfate Oral Solution.

27 Jun 2006

FDA approves Prezista (darunavir)

FDA approves Prezista (darunavir), a new drug for adults whose infection with the human immunodeficiency virus (HIV) has not responded to treatment with other antiretroviral drugs.

26 Jun 2006

Simple test for HIV for all of Washington DC

Washington DC has the the highest rate of new HIV and AIDS cases in the U.S.

26 Jun 2006

New push to tackle priorities in sexual and reproductive health

Leaders of the World Health Organization (WHO) and UNFPA, the United Nations Population Fund, are coordinating action to reverse the global trend of deteriorating levels of sexual and reproductive health and reduce the adverse impact on mothers, babies and young people.

20 Jun 2006

HIV positive women are much more likely to suffer from anaemia and high blood pressure in pregnancy

The researchers identified a number of key health issues facing HIV positive pregnant women.

19 Jun 2006

AIDS might be an accident of evolution

The virulence characteristic of HIV-1 - the virus predominantly responsible for human AIDS - might amount to an accident of evolution, new evidence reveals.

18 Jun 2006